Skip to main content

Advertisement

Table 5 Environmental information on pharmaceuticals that were publicly available in the PharmNet database in November 2018

From: The accessibility of data on environmental risk assessment of pharmaceuticals: Is the marketing authorisation procedure in conflict with the international right of access to environmental information?

API Total number of HMPs/VMPs for which the author searched the public national database* PAR available in database PAR with a chapter called Ecotoxicity/Environmental Risk Assessment Communicated result in PAR
Ciprofloxacin 1 1 1 No risk
Diclofenac 1 1 1 Risk
Ethinylestradiol 3 0 0
Ibuprofen 38 33 31 17× risk or risk cannot be excluded
8× no risk
6× no result
Iomeprol 3 0 0
Amoxicillin 2 2 2 2× no risk
Doxycyclin 2 0
Florfenicol 7 3 3 3× no risk
Sulfadoxin/Trimethoprim 1 0
Total 58 40 38  
  1. * Authorised in Germany and for which an ERA was included in the dossier